Therapeutic impact of the ethyl acetate extract of Tripterygium wilfordii Hook F on nephritis in NZB/W F1 mice

Arthritis Research and Therapy

Volumn 8, Issue 1, 2006, Pages

  Tao, Xuelian ^a   Fan, Fred ^a   Hoffmann, Victoria ^b   Longo, Nancy S ^a   Lipsky, Peter E ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; ACETIC ACID ETHYL ESTER; ANTIGEN ANTIBODY COMPLEX; ANTINUCLEAR ANTIBODY; DNA; HERBACEOUS AGENT;

ANIMAL; ANTIGEN ANTIBODY COMPLEX; BLOOD; CHEMISTRY; DRUG EFFECTS; FEMALE; IMMUNOLOGY; KIDNEY; LUPUS NEPHRITIS; LYMPHOCYTE; METABOLISM; MOUSE; NEW ZEALAND BLACK MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PROTEINURIA; SPLEEN; TRIPTERYGIUM; URINE;

ACETATES; ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; DNA; DRUGS, CHINESE HERBAL; FEMALE; KIDNEY; LUPUS NEPHRITIS; LYMPHOCYTES; MICE; MICE, INBRED NZB; PROTEINURIA; SPLEEN; TRIPTERYGIUM;

EID: 41749119619     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar1879     Document Type: Article

References (43)

1. Lipsky PE, Tao XL: A potential new treatment for rheumatoid arthritis: Thunder God Vine. Semin Arthritis Rheum 1997, 26 713-723.
2. Tao XL, Lipsky PE: The Chinese anti inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F. Rheum Dis Clin North America 2000, 26: 29-50.
3. Wang QW, Li LS, Zhang JH: Clinical studies of treatment of idiopathic IgA nephropathy with Tripterygium wilfordii Hook f. Jiang Su Yi Yao 1991, 1:7-9.
4. Li H, Cheng QR, Dong DC: Observation on clinical effect on treatment of IgA nephropathy with Tripterygium wilfordii Hook. Shanghai Yi Xue 1993, 16:223-224.
5. Peng SY, Guo SJ, Dong SR: Treatment of Henoch-Shoenlein purpura with total glycosides of Tripterygium wilfordii. Jiang Su Yi Yao 1983, 9:38-40.
6. Pan YR: Treatment of purpura nephritis with Tripterygium wilfordii Hook F. Acta Acad Med Sinicae 1987, 9:2-4.
7. Liao WQ: Observations on the therapeutic effect of Tripterygium wilfordii Hook f on systemic lupus ethythematosus. Pi Fu Beng Fang Zhi Yan Jiou Tong Xun 1980, 9:14-15.
8. Qin WZ, Yang SM, Zhu GD, Liu CH, Li F, Feng SF, Han KY, Tang GT, Gong ZM, Wang HT: Treating 103 cases of SLE with Tripterygium wilfordii Hook f. Chin J Dermatol 1982, 15:141-143.
9. Li ZM, Zheng CS: Observation on treatment of systemic lupus erythematosus with extract of Tripterygium wilfordii Hook Xin Zhong Yi 1982, 12:22-24.
10. Xue GY, Xue JH, Tang YC, Fan ZH: Treatment of 21 patients with SLE with Tripterygium wilfordii Hook. Zhong Hua Pi Fu Ko Za Zhi 1984, 17:201-203.
11. Gu WZ, Banerjee S, Rauch J, Brandwein SR: Suppression of renal disease and arthritis, and prolongation of survival in MRL-Apr mice treated with an extract of Tripterygium wilfordii Hook f. Arthritis Rheum 1992, 35:1381-1386.
12. Zhang XY, Tsuchiya N, Dohi M, Yamamoto K, Okadaira HK, Miyamoto T: Prolonged survival of MRL-lpr/Ipr mice treated with Tripterygium wilfordii Hook f. Clin Immun Immunopathol 1992, 62 66-71.
13. Andrews BS, Eisenberg RA, Theoflopous AN, Izui S, Wilson CB, McConahey ED, Muphy ED, Roths JB, Dixon RJ: Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978, 148:1198-1215.
14. Hahn B: Dubois' lupus erythematosus. In Animal Models of Systemic Lupus Erythematosus Edited by: Qallace HB. Baltimore: Williams and Wilkens; 1997:339-347.
15. Borel Y, Lewis RM, Andre-Schwatz J, Stollar BD, Diener E: Treatment of lupus nephritis in adult(NZB+NZW)F1 mice by cortisone- facilitated tolerance to nucleic acid antigens. J Clin Invest 1978, 61 276-286.
16. Hahn BH, Knotts L, Hamilton TR: Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/ NZW mice. Arthritis Rheum 1975, 18:145-152.
17. Schiffer L, Sinha J, Wang X, Huang W, Gonsdroff GV, Schiffer M, Madaio MP, Davidson A: Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition. J Immunol 1997, 71:489-505.
18. Wakeland EK, Liu K, Graham RR, Behrens TW: Delineating the genetic basis of systemic lupus erythematosus. Immunity 2001, 15 397-408.
19. Tao XL, Cush JJ, Garret MM, Lipsky PE: A phase I study of the ethyl acetate extract of the Chinese anti-rheumatic herb, Tripterygium wilfordii Hook F in rheumatoid arthritis. J Rheumatol 2001, 28:2160-2167.
20. Tao XL, Younger J, Wang B, Lipsky PE: Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis: A double-blind, placebo-controlled study. Arthritis Rheum 2002, 46:1735-1743.
21. Cai Ji, Tao XL, Lipsky PE: High performance liquid chromatography determination of triptolide and triptolide in ethyl acetate extract of Tripterygium wilfordii Hoo.F. J Liquid Chromatography 1994, 7:4479-4487.
22. Li LZ, Chen SF, Wang FJl: Pharmacological studies of the ethyl acetate extract of Tripterygium wilfordii Hook f. Zhong Cao Yao 1982, 13:27-32.
23. Tao XL, Davis LS, Lipsky PE: Effect of an extract of the Chinese herbal remedy, Tripterygium wilfordii Hook f on human immune responsiveness. Arthritis Rheum 1991, 34:1274-1281.
24. 2 of Tripterygium wilfordii Hook. f. J Parmacol Exp Ther 1995, 272:1305-1312.
25. 2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transaction. J Parmacol Exp Ther 1996, 276:316-325.
26. Macanovic M, Sinicrop D, Shak S, Baughman S, Thiru S, Lachmann PJ: The treatment of systemic lupus erythematosus (SLE) in NZB/W F1 hybrid mice; studies with recombinant murine DNase and with dexamethasone. Clin Exp Immunol 1996, 106:243-252.
27. Chan OTM, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ: A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999, 189:1639-1648.
28. Ramos MA, Pinera C, Setien MA, Buelta L, De Cos MA, Francisco ALM, Merino R, Arias M: Modulation of autoantibody production by mycophenolate mofetil: Effect on the development of SLE in (NZBxNZW)F1 mice. Nephrol Dial Transplant 2003, 18:878-883.
29. Tao XL, Ma L, Mao YP, Lipsky PE.: Suppression of carrageenaninduced inflammation in vivo by an extract of the Chinese herbal remedy, Tripterygium wilfordii Hook. Inflamm Res 1999, 48 139-148.
30. Li LZ, Chen SF, Wang: Effect of triptolide on inflammation and immune function. Zhong Guo Yao Li Xue Tong Bao 1986, 2 25-28.
31. Tao XL, Shi YP, Cheng XH, Zhang NZ: Mechanism of treating rheumatoid arthritis with Tripterygium wilfordii Hook. I. Effect on Secretion of total IgM and IgM-RF by peripheral blood mononuclear cells (PBMC). Acta Acad Med Sinicae 1988, 10:361-364.
32. 2 production. Arthritis Rheum 1998, 41:130.
33. Wang B, Ma L, Tao XL, Lipsky PE: Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. Arthritis Rheum 2004, 50 2995-3003.
34. Tao XL, MA L, Cai J, et al.: Treatment with an ethyl acetate extract of Tripterygium wilfordii Hook f improves joint inflammation in HLA B27 transgenic rats. (60th) National Scientific Meeting of American College of Rheumatology. Orlando, Florida. Arthritis Rheum 1996, 39:S298.
35. Okudaira H, Terada E, Okudaira K: Animal models utilize in the research of autoimmune disease control: Experimental therapy of glomerulaonephritis in NZB/W F1 mice. Prog Clin Biol Res 1987, 229:157-174.
36. Cassese G, de Lindenau S, Boer B, Arce S, Hauser A, Riemekasten G, Berek C, Hiepe F, Krenn V, Radbruch A: Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur J Immunol 2001, 31:2726-2732.
37. Dixon FJ, Lidstone MBA, Tonietti G: Pathogenesis immune complex glomerulonephritis of New Zealand mice. J Exp Med 1971, 134 65S-75S.
38. Chan OTM, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ: A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999, 189:1639-1648.
39. Waters ST, Mcduffie M, Bagavant H, Deshmukh US, Gaskin F, Jiang C, Tung K, Fu SM: Breaking tolerance to double stranded DNA, Nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med 2004, 199:255-264.
40. Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ: Toll-like receptor 9 control anti-DNA autoantibody production in murine lupus. J Exp Med 2005, 202:321-331.
41. Kim YH, Lee SH, Lee JY, Choi SW, Park JW, Kwon TK: Triptolide inhibits murine-inducible nitric oxide synthase expression by down-regulating lipopolysaccharide-induced activity of nuclear factor-kappa B and c-Jun NH2-terminal kinase. Eur J Pharmacol 2004, 494:1-9.
42. Zhuang WJ, Fong CC, Cao J, Ao L, Leung CH, Cheung HY, Xiao PG, Fong WF, Yang MS: Involvement of NF-kappaB and c-myc signaling pathways in the apoptosis of HL-60 cells induced by alkaloids of Tripterygium hypoglaucum (levl.) Hutch. Phytomedicine 2004, 11:295-302.
43. Jiang XH, Wong BC, Lin MC, Zhu GH, Kung HF, Jiang SH, Yang D, Lam SK: Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Oncogene 2001, 20:8009-8018.